Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1HIV Infections 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Fluorouracil 3Watchful Waiting 2Taxes 2Polymerase Chain Reaction 2Paclitaxel 2Light Coagulation 2Imiquimod 2Cisplatin 2Carboplatin 2cabozantinib 1Vorinostat 1Triage 1Specimen Handling 1Remote Patient Monitoring 1Radiotherapy 1Radiation 1Platinum 1Observation 1Nivolumab 1Mass Screening 1Magnetic Resonance Spectroscopy 1Laser Therapy 1Isotretinoin 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Histological Techniques 1Electrocoagulation 1Coal Tar 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Remote Patient Monitoring × Gynecologic × Clear all
NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

AIDS Malignancy Consortium

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡